Literature DB >> 32558217

Cognitive tests aid in clinical differentiation of Alzheimer's disease versus Alzheimer's disease with Lewy body disease: Evidence from a pathological study.

Martina Azar1, Silvia Chapman2, Yian Gu2, James B Leverenz3, Yaakov Stern2, Stephanie Cosentino2.   

Abstract

INTRODUCTION: Clinical differentiation between Alzheimer's disease (AD) and AD with Lewy body disease (LBD) is relatively imprecise. The current study examined pathologically confirmed group differences in neuropsychological functioning, and the classification ability of specific tests.
METHODS: Fifty-one participants with postmortem diagnoses of AD (n = 34) and AD plus LBD (n = 17) were drawn from the Predictors Study. One-way analyses of variance (ANOVAs) and χ2 analyses examined group differences in neuropsychological performance. Binary logistic regressions examined predictive utility of specific tests for pathological diagnosis.
RESULTS: Individuals with AD had better visuoconstruction (P = .006), phonemic fluency (P = .08), and processing speed than AD plus LBD (P = .013). No differences were found in memory, naming, semantic fluency, or set-switching. Processing speed and visuoconstruction predicted pathologic group (P = .03). DISCUSSION: Processing speed and visuoconstruction predicted postmortem diagnosis of AD versus AD plus LBD. Current results offer guidance in the selection and interpretation of neuropsychological tests to be used in the differential diagnosis of early dementia.
© 2020 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; Lewy body dementia; autopsy; diagnosis; neuropsychological performance

Year:  2020        PMID: 32558217      PMCID: PMC7880164          DOI: 10.1002/alz.12120

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  42 in total

Review 1.  Dementia with Lewy bodies: neuropathology.

Authors:  Dennis W Dickson
Journal:  J Geriatr Psychiatry Neurol       Date:  2002       Impact factor: 2.680

2.  [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].

Authors:  J Vaamonde-Gamo; J M Flores-Barragán; R Ibáñez; M Gudín; A Hernández
Journal:  Rev Neurol       Date:  2005 Sep 1-15       Impact factor: 0.870

3.  The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Authors:  L Hansen; D Salmon; D Galasko; E Masliah; R Katzman; R DeTeresa; L Thal; M M Pay; R Hofstetter; M Klauber
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

4.  Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease.

Authors:  M-P Perriol; K Dujardin; P Derambure; A Marcq; J-L Bourriez; E Laureau; F Pasquier; L Defebvre; A Destée
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

Review 5.  Neuropathological alterations in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Matthew P Frosch; Eliezer Masliah; Bradley T Hyman
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

6.  Clinical and neuropathological findings in Lewy body dementias.

Authors:  D Galasko; R Katzman; D P Salmon; L Hansen
Journal:  Brain Cogn       Date:  1996-07       Impact factor: 2.310

7.  Impact of Alzheimer's Disease, Lewy Body and Vascular Co-Pathologies on Clinical Transition to Dementia in a National Autopsy Cohort.

Authors:  Jagan A Pillai; Robert S Butler; Aaron Bonner-Jackson; James B Leverenz
Journal:  Dement Geriatr Cogn Disord       Date:  2016-09-14       Impact factor: 2.959

Review 8.  [Effectiveness of 123I-ioflupane (DaTSCAN) in the diagnosis of Parkinsonian syndromes. A systematic review].

Authors:  J Puñal Riobóo; L Varela Lema; A Serena Puig; A Ruano-Ravina
Journal:  Rev Esp Med Nucl       Date:  2007 Nov-Dec

9.  Early neuropsychological discriminants for Lewy body disease: an autopsy series.

Authors:  Hiroshi Yoshizawa; Jean Paul G Vonsattel; Lawrence S Honig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-10       Impact factor: 10.154

10.  The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders.

Authors:  David J Irwin; Howard I Hurtig
Journal:  J Alzheimers Dis Parkinsonism       Date:  2018-08-10
View more
  2 in total

1.  A Mini-Mental State Examination Formula May Help to Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.

Authors:  Tom Ala; Danah Bakir; Srishti Goel; Nida Feller; Albert Botchway; Cindy Womack
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

2.  Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF.

Authors:  Walter A Boiten; Inger van Steenoven; Mei-Fang Xiao; Paul F Worley; Barbara Noli; Cristina Cocco; Gian-Luca Ferri; Afina W Lemstra; Charlotte E Teunissen
Journal:  Cells       Date:  2020-12-29       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.